Precigen, Inc. ( PGEN) - Key Metrics
PGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | -$0.08 | -$0.07 | -$0.08 |
| 2025Q3 | $0.01 | -$0.49 | -$0.10 | -$0.10 |
| 2025Q2 | $0 | -$0.09 | -$0.06 | -$0.07 |
| 2025Q1 | $0 | -$0.18 | -$0.06 | -$0.06 |
PGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -13.92 |
| 2025Q3 | ? | -1.67 |
| 2025Q2 | ? | -3.95 |
| 2025Q1 | ? | -2.02 |
PGEN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -3.64% | ? |
| 2025Q4 | -1.84% | ? |
| 2025Q3 | -3.02% | ? |
| 2025Q2 | -4.74% | ? |
| 2025Q1 | -3.87% | ? |
PGEN
Price: $4.80
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.21 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4.3 million
Market Capitalization: 1.1 billion